In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies

Clinical trial NCT07239323 · RECRUITING

Trial details

NCT number: NCT07239323
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Acute Lymphoblastic Leukemia B Cell Non-Hodgkin's Lymphoma Multiple Myeloma

Start date: 2025-07-01
Primary completion: 2027-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.